Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (11): 1210-1215.doi: 10.3969/j.issn.1000-6621.2021.11.017
• Review Articles • Previous Articles Next Articles
LI Kang, CHAI Ying-hui, BAI Guang-liang, DENG Xian-ping, LEI Hong()
Received:
2021-07-02
Online:
2021-11-10
Published:
2021-11-02
Contact:
LEI Hong
E-mail:leihong_hospitol@126.com
LI Kang, CHAI Ying-hui, BAI Guang-liang, DENG Xian-ping, LEI Hong. Research progress of correlation between pulmonary tuberculosis and intestinal flora[J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1210-1215. doi: 10.3969/j.issn.1000-6621.2021.11.017
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.11.017
[1] |
Floyd K, Glaziou P, Houben RMGJ, et al. Global tuberculosis targets and milestones set for 2016—2035: definition and rationale. Int J Tuberc Lung Dis, 2018, 22(7):723-730. doi: 10.5588/ijtld. 17.0835.
doi: 10.5588/ijtld. 17.0835 |
[2] |
Druszczyńska M, Kowalewicz-Kulbat M, Fol M, et al. Latent M.tuberculosis infection-pathogenesis, diagnosis, treatment and prevention strategies. Pol J Microbiol, 2012, 61(1):3-10. doi: 10.33073/pjm-2012-001.
doi: 10.33073/pjm-2012-001 |
[3] |
孔维宾, 韩丹, 李梦秋, 等. 肺结核患者家属结核分枝杆菌潜伏感染状况及危险因素分析. 河南预防医学杂志, 2021, 32(1):10-12,16. doi: 10.13515/j.cnki.hnjpm.1006-8414.2021.01.003.
doi: 10.13515/j.cnki.hnjpm.1006-8414.2021.01.003 |
[4] |
Blum HE. The human microbiome. Adv Med Sci, 2017, 62(2):414-420. doi: 10.1016/j.advms.2017.04.005.
doi: 10.1016/j.advms.2017.04.005 |
[5] |
Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol, 2017, 15(1):55-63. doi: 10.1038/nrmicro.2016.142.
doi: 10.1038/nrmicro.2016.142 |
[6] |
Hsu BB, Plant IN, Lyon L, et al. In situ reprogramming of gut bacteria by oral delivery. Nat Commun, 2020, 11(1):5030. doi: 10.1038/s41467-020-18614-2.
doi: 10.1038/s41467-020-18614-2 |
[7] |
Chassaing B, Raja SM, Lewis JD, et al. Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans. Cell Mol Gastroenterol Hepatol, 2017, 4(2):205-221. doi: 10.1016/j.jcmgh. 2017.04.001.
doi: 10.1016/j.jcmgh. 2017.04.001 |
[8] |
陈硕, 聂汉祥, 刘琳琳, 等. 肠道菌群与支气管哮喘. 国际呼吸杂志, 2018, 38(2):129-132. doi: 10.3760/cma.j.issn.1673-436X.2018.02.011.
doi: 10.3760/cma.j.issn.1673-436X.2018.02.011 |
[9] |
Mukherjee S, Joardar N, Sengupta S, et al. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. J Nutr Biochem, 2018, 61:111-128. doi: 10.1016/j.jnutbio.2018.07.010.
doi: 10.1016/j.jnutbio.2018.07.010 |
[10] |
Schuijt TJ, Lankelma JM, Scicluna BP, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut, 2016, 65(4):575-583. doi: 10.1136/gutjnl-2015-309728.
doi: 10.1136/gutjnl-2015-309728 |
[11] |
Azad MB, Konya T, Persaud RR, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG, 2016, 123(6):983-993. doi: 10.1111/1471-0528.13601.
doi: 10.1111/1471-0528.13601 |
[12] |
Ruiz-Calderon JF, Cavallin H, Song SJ, et al. Walls talk: Microbial biogeography of homes spanning urbanization. Sci Adv, 2016, 2(2):e1501061. doi: 10.1126/sciadv.1501061.
doi: 10.1126/sciadv.1501061 |
[13] |
Chung KF. Airway microbial dysbiosis in asthmatic patients: A target for prevention and treatment? J Allergy Clin Immunol, 2017, 139(4):1071-1081. doi: 10.1016/j.jaci.2017.02.004.
doi: 10.1016/j.jaci.2017.02.004 |
[14] |
Mjösberg J, Rao A. Lung inflammation originating in the gut. Science, 2018, 359(6371):36-37. doi: 10.1126/science.aar4301.
doi: 10.1126/science.aar4301 |
[15] |
Khan N, Vidyarthi A, Nadeem S, et al. Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis. Front Immunol, 2016, 7:529. doi: 10.3389/fimmu.2016.00529.
doi: 10.3389/fimmu.2016.00529 |
[16] |
Zhang YB, Liu SJ, Hu ZD, et al. Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis. Cancer Immunol Immunother, 2020, 69(12):2665-2671. doi: 10.1007/s00262-020-02687-5.
doi: 10.1007/s00262-020-02687-5 |
[17] |
Camelo-Castillo AJ, Mira A, Pico A, et al. Subgingival microbiota in health compared to periodontitis and the influence of smoking. Front Microbiol, 2015, 6:119. doi: 10.3389/fmicb.2015.00119.
doi: 10.3389/fmicb.2015.00119 |
[18] |
杨翰, 李欢, 郗隽, 等. 初治结核病患者肠道菌群变性梯度凝胶电泳指纹图谱分析. 中国防痨杂志, 2019, 41(9):985-992. doi: 10.3969/j.issn.1000-6621.2019.09.013.
doi: 10.3969/j.issn.1000-6621.2019.09.013 |
[19] |
Maji A, Misra R, Dhakan DB, et al. Gut microbiome contri-butes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers. Environ Microbiol, 2018, 20(1):402-419. doi: 10.1111/1462-2920.14015.
doi: 10.1111/1462-2920.14015 |
[20] |
Khaliq A, Ravindran R, Afzal S, et al. Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting. PLoS One, 2021, 16(1):e0245534. doi: 10.1371/journal.pone.0245534.
doi: 10.1371/journal.pone.0245534 |
[21] |
Luo M, Liu Y, Wu P, et al. Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis. Front Physiol, 2017, 8:822. doi: 10.3389/fphys.2017.00822.
doi: 10.3389/fphys.2017.00822 |
[22] |
Huang SF, Yang YY, Chou KT, et al. Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans. Eur J Clin Invest, 2019, 49(5):e13068. doi: 10.1111/eci.13068.
doi: 10.1111/eci.13068 |
[23] |
Winglee K, Eloe-Fadrosh E, Gupta S, et al. Aerosol Mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiota. PLoS One, 2014, 9(5):e97048. doi: 10.1371/journal.pone.0097048.
doi: 10.1371/journal.pone.0097048 |
[24] |
Wipperman MF, Fitzgerald DW, Juste MAJ, et al. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Sci Rep, 2017, 7(1):10767. doi: 10.1038/s41598-017-10346-6.
doi: 10.1038/s41598-017-10346-6 |
[25] |
孙玉霞, 赵善良, 刘加洪, 等. 强化四周抗结核药物治疗对结核病患者肠道微生态影响分析. 实用预防医学, 2019, 26(10):1177-1182. doi: 10.3969/j.issn.1006-3110.2019.10.007.
doi: 10.3969/j.issn.1006-3110.2019.10.007 |
[26] |
Hu Y, Yang Q, Liu B, et al. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs. J Infect, 2019, 78(4):317-322. doi: 10.1016/j.jinf.2018. 08.006.
doi: 10.1016/j.jinf.2018. 08.006 |
[27] |
Scriba TJ, Carpenter C, Pro SC, et al. Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease History. Am J Respir Crit Care Med, 2017, 196(6):772-781. doi: 10.1164/rccm.201706-1208OC.
doi: 10.1164/rccm.201706-1208OC |
[28] |
Kovatcheva-Datchary P, Nilsson A, Akrami R, et al. Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella. Cell Metab, 2015, 22(6):971-982. doi: 10.1016/j.cmet.2015.10.001.
doi: 10.1016/j.cmet.2015.10.001 |
[29] |
Sandberg J, Kovatcheva-Datchary P, Björck I, et al. Abundance of gut Prevotella at baseline and metabolic response to barley prebiotics. Eur J Nutr, 2019, 58(6):2365-2376. doi: 10.1007/s00394-018-1788-9.
doi: 10.1007/s00394-018-1788-9 |
[30] |
Koh A, De Vadder F, Kovatcheva-Datchary P, et al. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 2016, 165(6):1332-1345. doi: 10.1016/j.cell.2016.05.041.
doi: 10.1016/j.cell.2016.05.041 |
[31] |
Nicolas GR, Chang PV. Deciphering the Chemical Lexicon of Host-Gut Microbiota Interactions. Trends Pharmacol Sci, 2019, 40(6):430-445. doi: 10.1016/j.tips.2019.04.006.
doi: 10.1016/j.tips.2019.04.006 |
[32] |
Hu Y, Feng Y, Wu J, et al. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients. Front Cell Infect Microbiol, 2019, 9:90. doi: 10.3389/fcimb. 2019.00090.
doi: 10.3389/fcimb. 2019.00090 |
[33] |
Frati F, Salvatori C, Incorvaia C, et al. The Role of the Microbiome in Asthma: The Gut Lung Axis. Int J Mol Sci, 2018, 20(1):123. doi: 10.3390/ijms20010123.
doi: 10.3390/ijms20010123 |
[34] |
Alverdy JC, Krezalek MA. Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of Sepsis. Crit Care Med, 2017, 45(2):337-347. doi: 10.1097/CCM. 0000000000002172.
doi: 10.1097/CCM. 0000000000002172 |
[35] |
Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science, 2012, 336(6086):1268-1273. doi: 10.1126/science.1223490.
doi: 10.1126/science.1223490 |
[36] |
Nadeem S, Maurya SK, Das DK, et al. Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis. Front Immunol, 2020, 11:726. doi: 10.3389/fimmu.2020.00726.
doi: 10.3389/fimmu.2020.00726 |
[37] |
Vorkas CK, Wipperman MF, Li K, et al. Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection. JCI Insight, 2018, 3(19):e121899. doi: 10.1172/jci.insight.121899.
doi: 10.1172/jci.insight.121899 |
[38] |
Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology, 2017, 151(4):363-374. doi: 10.1111/imm.12760.
doi: 10.1111/imm.12760 |
[39] |
Huang Y, Tang J, Cai Z, et al. Prevotella Induces the Production of Th17 Cells in the Colon of Mice. J Immunol Res, 2020, 2020:9607328. doi: 10.1155/2020/9607328.
doi: 10.1155/2020/9607328 |
[40] |
Huang Y, Mao K, Chen X, et al. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science, 2018, 359(6371):114-119. doi: 10.1126/science.aam5809.
doi: 10.1126/science.aam5809 |
[41] |
Bradley CP, Teng F, Felix KM, et al. Segmented Filamentous Bacteria Provoke Lung Autoimmunity by Inducing Gut-Lung Axis Th17 Cells Expressing Dual TCRs. Cell Host Microbe, 2017, 22(5):697-704. e4. doi: 10.1016/j.chom.2017.10.007.
doi: 10.1016/j.chom.2017.10.007 |
[42] |
Dheda K, Gumbo T, Maartens G, et al. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, patho-genesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. Lancet Respir Med, 2019, 7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2.
doi: 10.1016/S2213-2600(19)30263-2 |
[43] |
熊燕鹃, 罗和生. 肠道菌群与酒精性肝病. 胃肠病学和肝病学杂志, 2016, 25(9):1062-1065. doi: 10.3969/j.issn.1006-5709.2016.09.025.
doi: 10.3969/j.issn.1006-5709.2016.09.025 |
[44] |
Knackstedt R, Gatherwright J. The role of thermal injury on intestinal bacterial translocation and the mitigating role of probiotics: A review of animal and human studies. Burns, 2020, 46(5):1005-1012. doi: 10.1016/j.burns.2019.07.007.
doi: 10.1016/j.burns.2019.07.007 |
[45] |
毕紫娟, 张仕晟, 袁建业. 益生菌与肠易激综合征. 医学综述, 2017, 23(1):125-128,133. doi: 10.3969/j.issn.1006-2084.2017.01.029.
doi: 10.3969/j.issn.1006-2084.2017.01.029 |
[46] |
胡明, 李晓莉, 甄鹏, 等. 益生菌治疗老年肺炎的临床疗效及其对炎性反应、细胞免疫功能的影响. 实用心脑肺血管病杂志, 2019, 27(4):99-102. doi: 10.3969/j.issn.1008-5971.2019.04.017.
doi: 10.3969/j.issn.1008-5971.2019.04.017 |
[47] |
Yang Z, Wu Q, Liu Y, et al. Effect of Perioperative Probiotics and Synbiotics on Postoperative Infections After Gastrointestinal Surgery: A Systematic Review With Meta-Analysis. JPEN J Parenter Enteral Nutr, 2017, 41(6):1051-1062. doi: 10.1177/0148607116629670.
doi: 10.1177/0148607116629670 |
[48] |
Manzanares W, Lemieux M, Langlois PL, et al. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care, 2016, 19:262. doi: 10.1186/s13054-016-1434-y.
doi: 10.1186/s13054-016-1434-y |
[49] |
Dhakan DB, Maji A, Sharma AK, et al. The unique composition of Indian gut microbiome, gene catalogue, and associated fecal metabolome deciphered using multi-omics approaches. Gigascience, 2019, 8(3):giz004. doi: 10.1093/gigascience/giz004.
doi: 10.1093/gigascience/giz004 |
[50] |
Zmora N, Zilberman-Schapira G, Suez J, et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell, 2018, 174(6):1388-1405. e21. doi: 10.1016/j.cell.2018.08.041.
doi: 10.1016/j.cell.2018.08.041 |
[1] | WU Tuo-ya, SHI Jin, GUO Ji-dong, LIU Yuan-yuan, PANG Yu, LU Jie, GAO Fei. Mechanism of miR-21-3p modulating the survival of Mycobacterium tuberculosis in host macrophage [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 475-481. |
[2] | GUO Qian, SHEN Chen, SHEN A-dong. Research progress of stem cells in Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 186-189. |
[3] | QU Meng-jin, LIANG Zheng-min, WANG Yuan-zhi, ZHOU Xiang-mei. Research progress of carbohydrate metabolism of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 874-879. |
[4] | XIA Lu,LU Shui-hua,LIU Ping. Research progress of immune regulatory mechanism of traditional Chinese medicine on tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(2): 168-172. |
[5] | TANG Liang, BAO Yu-cheng, ZHANG Wen-long. Effects of anti-tubercular agents on intestinal flora and its influence on the organism [J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1333-1338. |
[6] | Bei-bei WU,Wei HUANG,Zhi-min WANG. The applications and problems of mesenchymal stem cells for the treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2019, 41(2): 233-235. |
[7] | SONG Rui-juan, LI Feng, LU Shui-hua. The research progress of mesenchymal stem cells as the adjuvant therapy of multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2017, 39(3): 299-303. |
[8] | WANG Li-min, GONG Rui, WU Yan-xiao, et al. The characteristics of bone metabolism in osteoporosis induced by spinal tuberculosis with paraplegia and its clinical significance [J]. Chinese Journal of Antituberculosis, 2016, 38(4): 266-269. |
[9] | Xu Xuqing,Liu Beidou,Li Qun,et al.. The comparative analysis of demographic characteristics and family disease financial burden of drug-resistant tuberculosis in Zhejiang [J]. Chinese Journal of Antituberculosis, 2004, 26(6): 332-335. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||